Finance · Search · Sign in · Sign up

Lai buys GMED 19.95: Piper Jaffray Raises Price Target on 'Top Pick' Globus Medical (GMED) to $28


Piper Jaffray analyst Matt Miksic reiterated an Overweight and 'Top Pick' rating and boosted his price target on Globus Medical (NYSE: GMED) to $28.00 (from $26.00) saying the current valuation as among the most compelling in their universe. Miksic said .. ...


20 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home